Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Dapagliflozin on Vascular Health in Patients With Type 2 Diabetes

NCT05139914 is registered in ClinicalTrials.gov with Boston University as lead sponsor.

NCT NCT05139914
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05139914 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Dapagliflozin on Vascular Health in Patients With Type 2 Diabetes
Lead sponsor
Boston University
Phase
Phase 4
Overall status
Terminated
Start date
May 31, 2022
Completion date
February 4, 2025
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2, endothelial dysfunction